According to the latest report by IMARC Group, titled "Vaccine Storage and Packaging Market Report by Segment (Vaccine Storage, Vaccine Packaging), Vaccine Storage Segment (Storage Equipment, Service), Vaccine Packaging Type (Packaging Type, Packaging Level), End User (Biopharmaceutical Companies, Hospitals, Medical Laboratories, and Others), and Region 2025-2033," the global vaccine storage and packaging market reached a value of USD 32.8 Billion in 2024. Vaccine storage and packaging are laboratory devices that are utilized to preserve and store vaccines in optimum temperatures and ensure proper handling of vaccine vials and ampoules during transportation and storage. These storage solutions, including refrigerators and freezers, are widely available in a vast range of capacities that vary depending upon the user requirements. Since exposure to temperatures outside the recommended range can reduce the potency and protection offered by the vaccines, they are packed in individual cylindrical vials and then bundled together in inner containers called cold boxes and vaccine carriers. Consequently, these devices are extensively used across blood banks, hospitals, pharmacies, medical laboratories, and other healthcare centers.
Global Vaccine Storage and Packaging Market Trends:
The global market is primarily driven by the increasing incidences of numerous viral infections and immunological disorders, which have impelled the need for efficient vaccine storage and packaging facilities. Moreover, the rising awareness among the masses regarding early diagnosis and prevention of infectious diseases has provided an impetus to the demand for protective vaccines, which, in turn, is anticipated to create a positive outlook for the market. This is being supported by the increasing focus of several governments on immunization programs, which has contributed to the escalating requirement for vaccine storage and packaging solutions across public clinics, hospitals and vaccination centers. The market is further driven by the continual technological advancements in cold chain facilities, which has led to the advent of storage solutions that offer minimal risks of vaccine freezing and improved quality control. Apart from this, the rapid outbreak of COVID-19 has created an escalating need for efficient storage and packaging equipment across the globe. Cold chain logistics companies are actively investing in the development of their infrastructure due to the rising requirement for efficient global distribution of the approved vaccines. Some of the other factors contributing to the market growth include extensive research and development (R&D) activities in the field of biotechnology, increasing government support toward research activities and clinical trials, and the growing number of pharma retailers on the global level. Looking forward, the market value is projected to reach USD 65.8 Billion by 2033, expanding at a CAGR of 7.63% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Segment, Vaccine Storage Breakup by Segment, Vaccine Packaging Breakup by Type, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | AmerisourceBergen Corporation, Arctiko A/S, Cardinal Logistics Management Corporation, DHL International GmbH (The Deutsche Post AG), Lineage Logistics LLC, McKesson Corporation, Nipro Corporation, PHC Holdings Corporation, Schenker Aktiengesellschaft and Thermo Fisher Scientific Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800